HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

France Advances Phthalate & Paraben Ban With National Assembly Vote

This article was originally published in The Rose Sheet

Executive Summary

Suspected endocrine disruptors phthalates and parabens could be banned in consumer products in France following a narrow vote in the country’s National Assembly.

You may also be interested in...



Regulatory News In Brief

FDA fires warning shot on Breathable Foods’ “inhalable caffeine”; agency guidance advises against phthalate excipients in drugs; pandemic adverse event reporting guidance finalized; Globe All Wellness recall of tainted supplements is insufficient; more Regulatory News In Brief.

Regulatory News In Brief

FDA fires warning shot on Breathable Foods’ “inhalable caffeine”; agency guidance advises against phthalate excipients in drugs; pandemic adverse event reporting guidance finalized; Globe All Wellness recall of tainted supplements is insufficient; more Regulatory News In Brief.

Canadian Activists Demand Regulation Of Endocrine Disruptors In Cosmetics

Canadian environmental and public health groups want to know why parabens, siloxanes, phthalates and bisphenol A are still "common ingredients in cosmetics" when Canadian law forbids the use of such potentially harmful substances.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017563

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel